King's tenure at FDA's Center for Tobacco Products was marked by significant criticism over the agency's handling of vaping product authorizations and oversaw the authorization of only a limited number of e-cigarette products, all of which are produced by major tobacco companies.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
